Related Experiment Video
Updated: Sep 25, 2025

In Vivo Mouse Model of Spinal Implant Infection
Published on: June 23, 2020
Improved Neurological Outcome in a Patient With Complicated Mitral Valve Endocarditis Treated With
Syed S Fatmi1, Rafaela Basso1, Ravitej Goteti1
1Internal Medicine, Southeast Health Medical Center, Dothan, USA.
Abstract:
Complicated infective endocarditis (IE) with symptomatic neurological involvement is associated with a poor prognosis. Vancomycin is the first-line antibiotic employed for the treatment of IE as general resistance of Methicillin-resistant Staphylococcus aureus (MRSA) to vancomycin is low and the antibiotic is well tolerated. In this case report, we describe a case of severely complicated MRSA endocarditis initially treated unsuccessfully with vancomycin. Our patient presented with severe encephalopathy with multiple septic infarctions noted on imaging. After treatment with a daptomycin-rifampin regimen, significant clinical improvement was noted. Based on the findings of this case report, what remains to be analyzed further with future studies is whether the daptomycin-rifampin regimen effect is independent of initial vancomycin-based treatment as most cases of IE are first treated with vancomycin and are only transitioned into daptomycin-rifampin regimen after treatment failure or persistent positive blood cultures, as is described in this case.
Insights
A complicated case of Methicillin-resistant Staphylococcus aureus (MRSA) endocarditis with neurological symptoms showed poor response to vancomycin. A daptomycin-rifampin regimen led to significant clinical improvement, suggesting a potential alternative treatment strategy.
Area of Science:
- Infectious Diseases
- Neurology
- Pharmacology
Background:
- Infective endocarditis (IE) caused by Methicillin-resistant Staphylococcus aureus (MRSA) with neurological involvement presents a significant treatment challenge.
- Vancomycin is typically the first-line antibiotic for MRSA IE due to generally low resistance rates and good tolerability.
Observation:
- This case report details a patient with severely complicated MRSA endocarditis and severe encephalopathy with multiple septic infarctions.
- Initial treatment with vancomycin was unsuccessful, failing to resolve the patient's severe symptoms and neurological complications.
Findings:
- Transitioning to a daptomycin-rifampin regimen resulted in marked clinical improvement in the patient's condition.
- This suggests that a daptomycin-rifampin combination may be effective in managing complex MRSA IE cases refractory to vancomycin.
Implications:
- Further studies are needed to determine if the efficacy of the daptomycin-rifampin regimen is independent of prior vancomycin treatment.
- This case highlights the potential for alternative antibiotic strategies in vancomycin-refractory MRSA IE, particularly when neurological complications are present.
Related Concept Videos
Endocarditis III: Medical Management
Mitral Stenosis III: Medical Management
Endocarditis IV: Nursing Management
Rheumatic Heart Disease III: Medical Management
Myocarditis III: Medical Management
Endocarditis I: Introduction

